AstraZeneca reaffirms Covid vaccine safety amid rare side effect concerns
7 months, 3 weeks ago

AstraZeneca reaffirms Covid vaccine safety amid rare side effect concerns

India TV News  

In response to recent concerns regarding potential rare side effects associated with the AstraZeneca-Oxford COVID-19 vaccine, the pharmaceutical company has underscored its unwavering commitment to patient safety while affirming the vaccine's overall safety profile. This comes in the wake of a recent admission by AstraZeneca, the pharmaceutical company, that its Covid vaccine Covishield and Vaxzevria "can, in very rare cases, cause Thrombosis Thrombocytopenia Syndrome." Notably in 2023, the World Health Organisation said in its report that TTS emerged as a new adverse event following immunisation in individuals vaccinated with COVID-19 non-replicant adenovirus vector-based vaccines. However, Union Health Minister Mansukh Mandaviya in March 2024 at 'ANI Dialogues - Navigating India's health sector' said that ICMR has done a detailed study which shows that COVID-19 vaccine is not responsible for heart attacks, and an individual's lifestyle and factors such as binge drinking could be among underlying causes.

Covid Vaccine Astrazeneca Tts Safety Amid Safety Amid Rare Rare Side Effect  vaccine  astrazeneca  tts  pharmaceutical  covid19  reaffirms  health  vaccines  effect  covid  safety  amid  rare  concerns

History of this topic

AstraZeneca's Covid vaccine linked to another rare blood disorder
7 months, 1 week ago

AstraZeneca's Covid vaccine linked to another rare blood disorder

India Today  

Over a week after AstraZeneca announced a global withdrawal of its vaccine against coronavirus citing a slowdown in sales and availability of enough options in the market, new research has linked it to a rare disorder. Researchers found that the AstraZeneca vaccine, sold in India under the brand name Covishield, is linked to a rare blood clotting disorder called Vaccine-Induced …

Covishield Side Effects: Doctors' Group Urges Govt to Review All Covid Vaccines
7 months, 1 week ago

Covishield Side Effects: Doctors' Group Urges Govt to Review All Covid Vaccines

News 18  

In the wake of pharmaceutical giant AstraZeneca admitting in a UK court that its Covid vaccine can cause blood clots in rare cases, a group of doctors on Thursday expressed deep concern over the safety of the Covishield vaccine manufactured by the Serum Institute of India. At a press conference, the doctors, under the banner of the Awaken India Movement, …

AstraZeneca withdraws Covishield pointing to low demand, but did rare side effects also play a role?
7 months, 2 weeks ago

AstraZeneca withdraws Covishield pointing to low demand, but did rare side effects also play a role?

The Hindu  

Published : May 09, 2024 13:21 IST - 3 MINS READ The pharmaceutical giant AstraZeneca has reportedly withdrawn its COVID-19 vaccine Vaxzevria, also known as Covishield, worldwide, citing commercial reasons for the decision. Vaxzevria saved millions of lives AstraZeneca, who developed the vaccine with Oxford University, said it was “incredibly proud of the role Vaxzevria played in ending the global …

AstraZeneca's Covishield Showed Lowest Incidence of Side Effects in India Versus Globally, Says Top Govt Official
7 months, 2 weeks ago

AstraZeneca's Covishield Showed Lowest Incidence of Side Effects in India Versus Globally, Says Top Govt Official

News 18  

AstraZeneca’s vaccine has demonstrated the lowest incidence of side effects in India compared to the global average, a top government official involved in the national roll-out of Covid-19 vaccination told News18. “But only around 50 cases witnessed Thrombosis with Thrombocytopenia Syndrome — a rare side effect caused by the jab — of the 180 crore doses administered against 4 to …

After AstraZeneca covid-19 vax recall worldwide, Serum says it stopped manufacturing jabs in Dec 2021
7 months, 2 weeks ago

After AstraZeneca covid-19 vax recall worldwide, Serum says it stopped manufacturing jabs in Dec 2021

Live Mint  

New Delhi: The Serum Institute of India on Wednesday said it has stopped making and supplying covid-19 vaccine Covishield after AstraZeneca, the British drugmaker that helped develop the vaccine, announced it too was withdrawing its version of the jab worldwide. The development follows the launch of a class action suit in the UK over allegations that the UK vaccine caused …

AstraZeneca withdraws Covid vaccine worldwide after admitting it can cause rare blood clots
7 months, 2 weeks ago

AstraZeneca withdraws Covid vaccine worldwide after admitting it can cause rare blood clots

The Independent  

The best of Voices delivered to your inbox every week - from controversial columns to expert analysis Sign up for our free weekly Voices newsletter for expert opinion and columns Sign up to our free weekly Voices newsletter Please enter a valid email address Please enter a valid email address SIGN UP I would like to be emailed about offers, …

Stopped manufacturing Covishield since December 2021, says Serum Institute
7 months, 2 weeks ago

Stopped manufacturing Covishield since December 2021, says Serum Institute

Hindustan Times  

Pune-based Serum Institute of India stopped manufacturing its anti-Covid-19 vaccine Covishield in 2021, according to a statement issued by the company on Wednesday after British-Swedish pharmaceutical manufacturer AstraZeneca announced it was withdrawing its vaccine against Covid, Vaxzevria, due to “commercial reasons” as demand for it decreased globally. Consequently, since December 2021, we have stopped the manufacturing and supply of additional …

AstraZeneca pulls its COVID-19 vaccine from the European market
7 months, 2 weeks ago

AstraZeneca pulls its COVID-19 vaccine from the European market

Associated Press  

LONDON — The pharma giant AstraZeneca has requested that the European authorization for its COVID-19 vaccine be pulled, according to the EU medicines regulator. In an update on the European Medicines Agency’s website Wednesday, the regulator said that the approval for AstraZeneca’s Vaxzevria had been withdrawn “at the request of the marketing authorization holder.” AstraZeneca’s COVID-19 vaccine was first given …

As AstraZeneca announces vaccine withdrawal, Serum Institute says stopped Covishield in 2021
7 months, 2 weeks ago

As AstraZeneca announces vaccine withdrawal, Serum Institute says stopped Covishield in 2021

New Indian Express  

NEW DELHI: Days after AstraZeneca admitted for the first time in court documents that their Covid-19 vaccine can cause a rare and dangerous side effect, the British pharma giant announced that they are withdrawing it globally. In its statement, AstraZeneca said, "As multiple, variant COVID-19 vaccines have since been developed, there is a surplus of available updated vaccines. According to …

AstraZeneca withdraws COVID-19 vaccine citing a decline in demand
7 months, 2 weeks ago

AstraZeneca withdraws COVID-19 vaccine citing a decline in demand

ABC  

In short: Pharmaceutical company AstraZeneca has started a global withdrawal of its COVID-19 vaccine, Vaxzevria, which has not been available in Australia since March 2023. Pharmaceutical company AstraZeneca has started a global withdrawal of its COVID-19 vaccine, Vaxzevria, which has not been available in Australia since March 2023. AstraZeneca has initiated the worldwide withdrawal of its COVID-19 vaccine due to …

AstraZeneca removes its Covid vaccine worldwide after rare and dangerous side effect linked to 80 deaths in Britain was admitted in court papers
7 months, 2 weeks ago

AstraZeneca removes its Covid vaccine worldwide after rare and dangerous side effect linked to 80 deaths in Britain was admitted in court papers

Daily Mail  

AstraZeneca is removing its Covid vaccine worldwide, months after the pharmaceutical giant admitted that it can cause a rare and dangerous side effect. The vaccine, once heralded as a 'triumph for British science', has come under intense scrutiny in recent months for a very rare side effect causing blood clots and low blood platelet counts. The AstraZeneca jab was the …

COVID-19 vaccines: Much ado about known unknowns
7 months, 2 weeks ago

COVID-19 vaccines: Much ado about known unknowns

The Hindu  

There are things we know that we don’t know. This risk was identified and flagged back in 2021; packaging was modified to insert information associated with the side effects; even the WHO wrote about it first in May 2021 and then in 2023.Read Bindu Shajan Perapaddan’s report on the rare vaccine side-effect is “no secret” and they are “well aware …

‘Safety is primary focus’: Covaxin-developer amid reports on AstraZeneca vaccine
7 months, 3 weeks ago

‘Safety is primary focus’: Covaxin-developer amid reports on AstraZeneca vaccine

Hindustan Times  

Amid reports over potential rare side effects of the AstraZeneca-Oxford COVID-19 vaccine, Bharat Biotech, which developed the Covaxin, said in a statement that the vaccine was developed with a "single-minded focus on safety first." It stated that Covaxin was the "only Covid vaccine" in government of India's COVID-19 immunisation program to have conducted efficacy trials in India. "@bharatbiotech announcement - …

PM Modi's photo removed from vaccine certificates amidst Covishield controversy
7 months, 3 weeks ago

PM Modi's photo removed from vaccine certificates amidst Covishield controversy

Deccan Chronicle  

New Delhi: Amidst the ongoing controversy surrounding the Covishield vaccine, Prime Minister Narendra Modi's photograph has been removed from Covid-19 vaccine certificates. While speculation arose linking this action to AstraZeneca's acknowledgment of rare blood clotting cases associated with the vaccine, official sources have attributed it to the implementation of the election model code of conduct. The court had dismissed a …

Covishield: Gujarat Cong Demands Compensation, BJP Claims Heart Attacks Not Linked to Vaccine
7 months, 3 weeks ago

Covishield: Gujarat Cong Demands Compensation, BJP Claims Heart Attacks Not Linked to Vaccine

News 18  

The opposition Congress on Wednesday alleged that the BJP government at the centre did not follow the guidelines of the World Health Organisation, and demanded that the relatives of those who died due to heart attack or similar reasons after taking the Covishield vaccine against coronavirus should be paid compensation. Doctors associated with the Gujarat BJP, however, said a study …

Covishield | Plea in Supreme Court for probe panel for vaccine’s ‘risk factors’
7 months, 3 weeks ago

Covishield | Plea in Supreme Court for probe panel for vaccine’s ‘risk factors’

The Hindu  

The controversy over the safety aspects of the Covishield vaccine reached the Supreme Court on Wednesday, May 1, 2024, with a petition seeking the constitution of an expert medical panel to study the risk factors. Now after the document filed in UK court by the developer of Covishield, we are compelled to think on the risk and hazardous consequences of …

Only 7 Out 10 Lakh May Face Clotting Risk Due to Covishield: Former ICMR Scientist
7 months, 3 weeks ago

Only 7 Out 10 Lakh May Face Clotting Risk Due to Covishield: Former ICMR Scientist

News 18  

Only seven to eight individuals out of 10 lakh, who receive the coronavirus vaccine Covishield, face the risk of experiencing a rare side effect known as thrombosis thrombocytopenia syndrome. India’s top epidemiologist, former ICMR scientist Dr Raman Gangakhedkar, said those who got this vaccine have “no risk at all”. Gangakhedkar, who is known for his simplistic approach to clearing complicated …

AstraZeneca’s submission in U.K. court nothing new, say doctors over Covishield’s potential to cause blood clots
7 months, 3 weeks ago

AstraZeneca’s submission in U.K. court nothing new, say doctors over Covishield’s potential to cause blood clots

The Hindu  

Following pharmaceutical company AstraZeneca’s admission in U.K. court documents that its vaccine against COVID-19 has the potential to cause Thrombosis with Thrombocytopenia Syndrome, a rare side effect associated with blood clotting, doctors in India said this is not new information and that they are “well aware of the warning which has been available in India as an insert with the …

AstraZeneca admits its Covishield vaccine may lead to rare side effect
7 months, 3 weeks ago

AstraZeneca admits its Covishield vaccine may lead to rare side effect

New Indian Express  

As reported by The Telegraph, although AstraZeneca is disputing the allegations, it acknowledged in a legal filing submitted to the High Court in February that the vaccine "can, in very rare instances, lead to TTS." AstraZeneca, in a May 2023 response to Scott's lawyers, contested any direct link between the vaccine and TTS, stating they do not accept such a …

AstraZeneca admits in court that its Covid vaccine can cause rare side-effect ‘TTS’, what is it?
7 months, 3 weeks ago

AstraZeneca admits in court that its Covid vaccine can cause rare side-effect ‘TTS’, what is it?

Hindustan Times  

Pharmaceutical giant AstraZeneca has accepted for the first time that its Covid vaccine “can, in very rare cases, cause TTS”. {{^usCountry}} {{/usCountry}} AstraZeneca has been fighting a class action lawsuit that alleges its Covid vaccine, which was developed with the help of University of Oxford, has led to several deaths and serious injury. {{^userSubscribed}} {{/userSubscribed}} {{^userSubscribed}} {{/userSubscribed}} Responding to Scott's …

UK-Based AstraZeneca Acknowledges Rare Health Risk Of Its Covid Vaccine In Court
7 months, 3 weeks ago

UK-Based AstraZeneca Acknowledges Rare Health Risk Of Its Covid Vaccine In Court

News 18  

UK-based AstraZeneca has acknowledged in court that its Covid vaccine can cause a rare blood clotting condition, British media reports said on Monday. The admission comes amid legal proceedings triggered by claims that the vaccine led to serious health complications, The Daily Mail reported. In a legal document submitted to a UK court in February, the Cambridge-based company conceded that …

Health chiefs 'failed to sound alarm over potential dangers of Covid vaccines': MPs accuse regulator of putting Brits 'at serious risk' by not immediately sharing how Pfizer jabs could trigger extreme
9 months, 3 weeks ago

Health chiefs 'failed to sound alarm over potential dangers of Covid vaccines': MPs accuse regulator of putting Brits 'at serious risk' by not immediately sharing how Pfizer jabs could trigger extreme

Daily Mail  

Britain's medicines regulator has been accused of failing to sound the alarm over Covid jab side effects, despite allegedly knowing of heart risks for months before warnings were issued. The AAPG letter, penned by its co-chair Graham Stringer the Labour MP for Blackley and Broughton, called for an urgent investigation to be held into The Medicines and Healthcare products Regulatory …

Global study quantifies rise in blood clots, heart inflammation following COVID-19 vaccination
10 months ago

Global study quantifies rise in blood clots, heart inflammation following COVID-19 vaccination

The Hindu  

One of the largest assessments of its kind, spanning 99 million people and investigating reports of adverse reactions following COVID-19 vaccination, found that instances of Guillain Barre Syndrome, myocarditis, pericarditis and cerebral venous sinus thrombosis were at least 1.5 times more than expected following inoculation with mRNA and ChadOX1 vaccines. The Global Covid Vaccine Safety Project, which made the assessment, …

AstraZeneca strikes £880m deal to buy US vaccine maker amid questions over Covid jab
1 year ago

AstraZeneca strikes £880m deal to buy US vaccine maker amid questions over Covid jab

The Telegraph  

Iskra Reic, executive vice president of vaccines and immune therapies at AstraZeneca, said: “This aligns with our strategy to deliver a portfolio of therapies to address high unmet needs in infectious diseases, and our ambition to protect the most vulnerable patients who have high risk of severe outcomes.” Shares in AstraZeneca rose 1.3pc in afternoon trade on news of the …

AstraZeneca vaccine linked with ‘spike’ in cases of rare disease that can paralyse victims
1 year ago

AstraZeneca vaccine linked with ‘spike’ in cases of rare disease that can paralyse victims

The Telegraph  

Scientists have drawn a link between the Oxford-AstraZeneca vaccine and a “spike” in cases of a rare disease that can leave its victims paralysed. Two of the studies looked at rates of GBS in England and said there was an increase in cases “attributable to” the AstraZeneca vaccine, or that there was a probable “causal link”. ‘Side effects ignored’ Anthony …

How safe is AstraZeneca's Covid jab? What rare complications can it cause? Who is taking legal action against the pharma giant? All you need to know
1 year, 1 month ago

How safe is AstraZeneca's Covid jab? What rare complications can it cause? Who is taking legal action against the pharma giant? All you need to know

Daily Mail  

As Brits take AstraZeneca to court we recount what happened with the Covid jab AstraZeneca's Covid vaccine undoubtedly saved millions of lives. AstraZeneca's Covid jab timeline January 2020: Oxford University scientists start working on a Covid vaccine after the World Health Organization declares the spread of the virus a 'Public Health Emergency of International Concern' March 2020: Then Prime Minister …

Is AstraZeneca's Covid jab 'defective'? How firm that supplied 50million doses to the UK could face £90million lawsuit over rare blood clot side effect
1 year, 1 month ago

Is AstraZeneca's Covid jab 'defective'? How firm that supplied 50million doses to the UK could face £90million lawsuit over rare blood clot side effect

Daily Mail  

AstraZeneca said jab has 'acceptable safety profile' and regulators state that the benefits outweigh the risks of 'extremely rare potential side-effects' The jabs were dished out 50million times in the UK during the Covid pandemic The AstraZeneca Covid vaccine has been labelled 'defective' in a multi-million-pound lawsuit by patients who suffered a rare side-effect. IT engineer Jamie Scott suffered a …

The victims of AstraZeneca's vaccine
1 year, 7 months ago

The victims of AstraZeneca's vaccine

Daily Mail  

Jab complications were rare but the massive rollout saw dozens of Brits killed Covid vaccines are estimated to have saved millions of lives, by both protecting people from the virus and helping end the paralysing series of lockdowns. An inquest heard he was told there was no Pfizer jab in stock and was given out-of-date information in relation to blood …

India restarts Covid vaccine production as new infections soar 30% in one day
1 year, 8 months ago

India restarts Covid vaccine production as new infections soar 30% in one day

The Independent  

India is ramping up its vaccine production following a rapid surge in Covid-19 cases driven by a new subvariant dubbed Arcturus. The country recorded 10,158 news Covid cases on Thursday, a 30 per cent surge in one day, according to the federal health ministry data. The company stopped manufacturing Covishield in December 2021 due to dwindling demand and a low …

’Covishield shouldn’t have been rolled out’: Doctor flags ’severe’ side-effects
1 year, 10 months ago

’Covishield shouldn’t have been rolled out’: Doctor flags ’severe’ side-effects

Live Mint  

A well known British-Indian cardiologist has flagged the cardiovascular side effects of the Covishield vaccine. According to Dr Aseem Malhotra, the vaccine manufactured in India by the Serum Institute is ‘even worse’ than mRNA COVID-19 vaccines when it came to concerns such as heart attacks and strokes. Citing a comparison published in a peer-reviewed journal, he said that the Oxford-AstraZeneca …

‘Erroneous’: Centre dismisses Covid vaccine's ‘multiple side effects’ report
1 year, 11 months ago

‘Erroneous’: Centre dismisses Covid vaccine's ‘multiple side effects’ report

Hindustan Times  

Union ministry of health and family welfare on Tuesday dismissed media reports regarding the Indian Council of Medical Research and Central Drugs Standard Control Organisation admitting to ‘multiple side-effects Covid-19 vaccines'. Terming the report “erroneous”, the ministry said that ICMR has only provided a list of benefits and drawbacks of the Covid-19 vaccine. Read| Centre unlikely to procure more Covid …

Multiple COVID vaccine side-effects: Health Ministry clears air on recent report
1 year, 11 months ago

Multiple COVID vaccine side-effects: Health Ministry clears air on recent report

Live Mint  

The Union Health Ministry has reiterated that only a small percentage of patients who receive the COVID-19 vaccine may develop serious adverse events depending on certain predisposing circumstances, refuting the reports of various side effects of the vaccine. According to a recent media report, the Central Drugs Standard Control Organization and the Indian Council of Medical Research have acknowledged "multiple …

DCGI Approves Market Authorisation for SII's Covid Vaccine Covovax as Heterologous Booster Dose
1 year, 11 months ago

DCGI Approves Market Authorisation for SII's Covid Vaccine Covovax as Heterologous Booster Dose

News 18  

The Drug Controller General of India has approved market authorisation to COVID-19 vaccine Covovax as a heterologous booster dose for adults who have been administered two doses of Covishield or Covaxin, official sources said on Monday. Prakash Kumar Singh, Director of Government and Regulatory Affairs at the Serum Institute of India, had recently written to the DCGI for the approval …

mRNA Covid-19 vaccines can increase serious adverse events? US researcher claims
1 year, 11 months ago

mRNA Covid-19 vaccines can increase serious adverse events? US researcher claims

India TV News  

A US-based researcher has claimed that the messenger RNA Covid-19 vaccine can increase serious adverse events in people, including sudden cardiac deaths. Joseph Fraiman, the lead author of the peer-reviewed research that re-analysed Pfizer & Moderna trials for mRNA Covid-19 vaccine, has tweeted: "I believe the mRNA Covid-19 vaccines need to be withdrawn". In another tweet, he mentioned that the …

SII Seeks Drug Regulator's Nod for Market Authorisation of Covovax Vaccine as Covid-19 Booster Dose
2 years ago

SII Seeks Drug Regulator's Nod for Market Authorisation of Covovax Vaccine as Covid-19 Booster Dose

News 18  

The Serum Institute of India has sought the drug regulator’s approval for market authorisation of its COVID-19 vaccine Covovax as a booster dose for those aged 18 years and above who have been administered two doses of Covishield or Covaxin, official sources said on Thursday. Prakash Kumar Singh, director, government and regulatory affairs, SII, submitted a market authorisation application for …

Study confirms AstraZeneca jab’s higher risk of very rare clot
2 years, 1 month ago

Study confirms AstraZeneca jab’s higher risk of very rare clot

The Hindu  

AstraZeneca's Covid vaccine has been linked to a 30% higher risk of getting a very rare blood clotting condition compared to the Pfizer jab, a large international study said Thursday. Several countries have already altered their advice after previous research indicated that -- in a tiny number of cases -- thrombosis with thrombocytopenia syndrome can be a possible side effect …

AstraZeneca Covid Jab Linked to 30% Higher Risk of Very Rare Blood Clot: Study
2 years, 1 month ago

AstraZeneca Covid Jab Linked to 30% Higher Risk of Very Rare Blood Clot: Study

News 18  

AstraZeneca’s Covid vaccine has been linked to a 30-percent higher risk of getting a very rare blood clotting condition compared to the Pfizer jab, a large international study said Thursday. Several countries have already altered their advice after previous research indicated that — in a tiny number of cases — thrombosis with thrombocytopenia syndrome can be a possible side effect …

AstraZeneca Nasal Spray Vaccine for Covid-19 Suffers Setback in Early Trial
2 years, 2 months ago

AstraZeneca Nasal Spray Vaccine for Covid-19 Suffers Setback in Early Trial

News 18  

In a major setback, AstraZeneca and the University of Oxford’s joint trial for the nasal-spray version of the Nonreplicating viral vector vaccine against Covid-19 did not yield desired protection, reported Reuters on Tuesday. The University of Oxford said, “An antibody response in the respiratory mucous membranes was seen in only a minority of participants in the trial, which was in …

Will Two ‘Made-in-India’ Vaccines Be the New Covid Boosters? News18 Decodes Differences
2 years, 3 months ago

Will Two ‘Made-in-India’ Vaccines Be the New Covid Boosters? News18 Decodes Differences

News 18  

India will soon roll out mRNA shots and intranasal vaccines, which will be available on CoWIN, and can be used as boosters against Covid-19. India’s first mRNA shot is only the third mRNA vaccine to be approved for Covid-19 in the world after Pfizer and Moderna. But mortality will be reduced.” Sharing a study of the intranasal vaccines under clinical …

Corbevax approved as booster for those jabbed with Covishield, Covaxin: Report
2 years, 4 months ago

Corbevax approved as booster for those jabbed with Covishield, Covaxin: Report

Live Mint  

The government has approved Biological E's Corbevax as a precaution dose for those above 18 years fully vaccinated with either Covishield or Covaxin, news agency PTI has reported on 10 August citing official sources. "Corbevax will be considered as a precaution dose after completion of six months or 26 weeks from the date of administration of the second dose of …

Adults may get different vaccine as booster shot instead of Covishield, Covaxin
2 years, 4 months ago

Adults may get different vaccine as booster shot instead of Covishield, Covaxin

Live Mint  

As the government has continued to emphasize Covid booster doses due to the rising number of cases, a panel has recommended a different vaccine for Indian adults. Government panel National Technical Advisory Group on Immunisation has recommended Biological E's Corbevax as a precaution dose for adults fully vaccinated with either Covishield or Covaxin. "Corbevax may be considered for a third/precaution …

Allowing Corbevax as booster for those vaccinated with Coivishield, Covaxin likely to be considered by NTAGI
2 years, 5 months ago

Allowing Corbevax as booster for those vaccinated with Coivishield, Covaxin likely to be considered by NTAGI

The Hindu  

Allowing Biological E’s Corbevax as a booster for those fully vaccinated against COVID-19 with either Covishield or Covaxin is likely to be considered by the NTAGI, which is scheduled to meet on Tuesday, sources said. “The National Technical Advisory Group on Immunisation will discuss allowing Corbevax, which has been cleared by the DCGI, as a booster for those fully vaccinated …

Over 42 lakh deaths in India prevented by COVID-19 vaccines in 2021: Lancet study
2 years, 5 months ago

Over 42 lakh deaths in India prevented by COVID-19 vaccines in 2021: Lancet study

The Hindu  

COVID-19 vaccines prevented over 42 lakh potential deaths in India in 2021, said a study published in The Lancet Infectious Diseases journal, which based its findings on estimates of "excess" mortalities in the country during the pandemic. In the first year of the vaccination programme, 19.8 million out of a potential 31.4 million COVID-19 deaths were prevented worldwide, according to …

Corbevax gets DCGI nod as COVID-19 booster after two doses of Covishield or Covaxin
2 years, 6 months ago

Corbevax gets DCGI nod as COVID-19 booster after two doses of Covishield or Covaxin

The Hindu  

Hyderabad-based Biological E. Limited ’s COVID-19 vaccine Corbevax has been approved by the Drug Controller General of India as a heterologous COVID-19 booster dose to individuals aged 18 years and above after 6 months of administration of primary vaccination of Covaxin or Covishield vaccines for restricted use in emergency situations. ‘’Recently, BE furnished its clinical trials data to the DCGI, …

Corbevax Gets DCGI Approval As Covid-19 Vaccine Booster Dose For 18 Years And Above
2 years, 6 months ago

Corbevax Gets DCGI Approval As Covid-19 Vaccine Booster Dose For 18 Years And Above

ABP News  

New Delhi: The Drug Controller General of India approved the Corbevax Covid-19 booster as heterologous Covid-19 booster dose for adults above the age of 18 years who got their primary Covid-19 vaccination of Covishield or Covaxin administered six months before, reported news agency ANI. Recently, BE has furnished its clinical trials data to the DCGI who after a detailed evaluation …

Biological E’s Corbevax gets DCGI nod as heterologous Covid booster dose
2 years, 6 months ago

Biological E’s Corbevax gets DCGI nod as heterologous Covid booster dose

Live Mint  

Hyderabad-based pharma company Biological E. Limited on Saturday announced that its Covid-19 vaccine CORBEVAX has been approved by the Drug Controller General of India as a heterologous Covid-19 booster dose for adults. Now, individuals aged 18 years and above who have already taken two doses of either Covishield or Covaxin can now receive a dose of Corbevax as a heterologous …

Corbevax gets DCGI nod as Covid-19 booster dose
2 years, 6 months ago

Corbevax gets DCGI nod as Covid-19 booster dose

India TV News  

Highlights Biological E's Corbevax vaccine has been cleared for a booster dose for those 18 and above. The Drugs Controller General Of India had earlier approved Corbevax, India's first indigenously developed RBD protein subunit vaccine, for restricted use in emergency situations for those aged five and above.A press release from the vaccine maker said the Corbevax can be administered as …

New plant-based Covid vaccine 70% effective against variants: Study
2 years, 7 months ago

New plant-based Covid vaccine 70% effective against variants: Study

India Today  

A new plant-based Covid-19 vaccine is nearly 70 per cent effective against symptomatic disease caused by five variants of the coronavirus, according to results of the human clinical trial of the preventive. The study, published on Thursday in the New England Journal of Medicine, shows that the vaccine efficacy was 69.5 per cent against any symptomatic Covid-19 caused by five …

'New plant-based COVID-19 vaccine 70% effective against variants'
2 years, 7 months ago

'New plant-based COVID-19 vaccine 70% effective against variants'

Firstpost  

The vaccine developed by researchers at Canadian biotechnology company Medicago contains coronavirus-like particles produced in plants which are combined with an adjuvant that helps vaccines work better Toronto: A new plant-based COVID-19 vaccine is nearly 70 per cent effective against symptomatic disease caused by five variants of the coronavirus, according to results of the human clinical trial of the preventive. …

Discover Related